Search

everythinglearnresearchcommunity

for

Search:↓

Activating β-catenin in certain skin cells speeds up hair growth in mice.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Balding people may have higher heart disease risk.

Transcutol P best increases Finasteride absorption for hair loss treatment.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Lithium therapy may cause temporary hair loss, with possible regrowth if treatment is stopped or continued.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Timing of light therapy affects horse coat growth, with photoperiod being crucial.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Hair characteristics might be early signs of Type 2 Diabetes and could help with early prevention.

Alternative treatments show promise for hair growth beyond traditional methods.

Hair loss may indicate higher heart risk and metabolic issues.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.